Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional Trial

NCT00924131 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 157

Last updated 2017-07-02

No results posted yet for this study

Summary

Background:

* Researchers are greatly interested in knowing more about the long-term effects of various treatments for cancers such as Hodgkin's disease, particularly from those who have lived 20 to 30 years after treatment.
* Patients who were treated at the National Institutes of Health (NIH) may have undergone different treatments for which more long-term information is needed.

Objectives:

* To examine the body systems of long-term survivors of Hodgkin's disease to see if there are any long- term consequences of treatment for Hodgkin's disease.
* To learn more about the long-term effects of cancer treatments.

Eligibility:

* Survivors of Hodgkin's disease who were previously treated at the NIH.
* Participants must be at least 18 years of age.

Design:

* Participants will need to sign consent forms to allow researchers to obtain documentation of medical history, including prior treatment for Hodgkin's disease and prior NIH treatment, including protocol number, where applicable:
* Pertinent medical records, pathology reports, and radiographic imaging studies will be reviewed.
* Primary care physician's name, address, and other contact information are also required.
* Evaluations during the assessment period:
* Complete physical examination.
* Laboratory studies of blood, urine, and stool samples.
* Radiologic evaluations, including computerized tomography (CT) and magnetic resonance imaging (MRI) scans for all participants and mammograms for females.
* Cardiac evaluation, vascular studies, and pulmonary studies to measure heart and lung function, and digestive tests to measure stomach and intestinal function.
* Neurocognitive testing to measure brain function.
* Optional skin biopsy.
* Participants will be asked to complete questionnaires assessing current quality of life and daily living skills.

Conditions

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    lead NIH

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-17
Completion
2010-05-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00924131 on ClinicalTrials.gov